Company profile

Otto Bock Healthcare Products GmbH

Otto Bock Healthcare Products GmbH has 2 AI-enabled medical devices on the FDA list. The first decision was on September 4, 2019 and the most recent on April 22, 2026 (myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T)). Its most common review panel is Neurology (2 devices).

2AI devices
2019First decision
2026Latest decision
1Specialties

Related guides

Top neurology devices

Timeline

  1. myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T) · Neurology · GXY
  2. Myo Plus · Neurology · GXY